AI Science Tracker

Multi-omics machine learning prioritizes a plasma lipid signature for active tuberculosis differentiation

Inje University College of Medicine; Ton Duc Thang University; Hanoi University of Pharmacy; University of Copenhagen; Korea University Guro Hospital · 1 Jul 2025 · medicine

Discovery

Multi-omics machine learning prioritizes a plasma lipid signature for active tuberculosis differentiation

Machine-learning integration of plasma functional-omics data in two discovery cohorts and a validation cohort identified biosignatures that distinguished active tuberculosis from nontuberculous mycobacterial infection, latent TB infection and other lung diseases. Cohorts included 76 people in the TB–NTM discovery set, 72 in the TB–LTBI–other-lung-disease set, and 68 TB plus 30 LTBI participants in the validation set. PC(14:0_22:6) was the most important predictor and was lower in active TB; additional external datasets yielded reported AUCs of 0.77–1.00.

Technology: Multi-omics integration and machine-learning predictive models for feature selection and classification

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Machine-learning integration of plasma functional-omics data in two discovery cohorts and a validation cohort identified biosignatures that distinguished active tuberculosis from nontuberculous mycobacterial infection, latent TB infection and other lung diseases.
  • Still unknown: The article calls PC(14:0_22:6) a candidate differential-diagnostic biomarker. Reported AUCs vary by comparator group and dataset; they do not establish prospective performance, clinical utility, or replacement of microbiological diagnosis. The PubMed abstract does not provide all cohort-level assay details, so this summary remains bounded to abstract-reported information.
  • AI role: The authors used machine-learning predictive modeling across integrated functional-omics measurements to identify and prioritize plasma signatures that discriminate active TB from clinically relevant non-TB groups. PC(14:0_22:6) emerged as the leading lipid feature; the analysis was evaluated across discovery, validation and two external datasets.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/40598791/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 12 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.